Liver shunt study tracks Real-World outcomes for 852 patients

NCT ID NCT03973372

Ongoing Knowledge-focused Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 852 adults with liver cirrhosis who are scheduled for a TIPS procedure, a shunt placed in the liver to relieve dangerous high blood pressure. Researchers will collect information from standard medical care over 5 years to learn how to best use TIPS and reduce complications like confusion or liver failure. The goal is to improve future treatment decisions, not to test a new drug or device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS, LIVER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS)

Contacts and locations

Locations

Baylor Scott & White Liver Consultants of Texas

Dallas, Texas, 75246, United States
Columbia University

New York, New York, 10032, United States
Mayo Clinic Rochester

Rochester, Minnesota, 55905, United States
Northwestern

Chicago, Illinois, 60611, United States
Scripps Health

San Diego, California, 92121, United States
Stanford

Redwood City, California, 94063, United States
University of Arizona

Phoenix, Arizona, 85006, United States
University of California San Francisco

San Francisco, California, 94115, United States
University of Chicago

Chicago, Illinois, 60637, United States
University of Florida

Gainesville, Florida, 32608, United States
University of Minnesota

Minneapolis, Minnesota, 55455, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
University of Wisconsin Madison

Madison, Wisconsin, 53705, United States
Weill Cornell

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.